Vimarsana
Biggest News Aggregation in the World

Page 6 - Clinical Laboratory Evaluation Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Laboratory Evaluation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Laboratory Evaluation Program Today - Breaking & Trending Today

New York State Approves SQI Diagnostics' EXACT COVID-19 Antibody Assay - Vimarsana News

New York State Approves SQI Diagnostics' EXACT COVID-19 Antibody Assay

/PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), leaders in the science of lung health, announced today that New York...

Medicare Contractor's Final Coverage Decision on NGS Cancer Testing Appeases Industry Stakeholders - Vimarsana News

Medicare Contractor's Final Coverage Decision on NGS Cancer Testing Appeases Industry Stakeholders

The LCD covers tests that are FDA approved or cleared, have published analytical validity evidence, or are certified by a third party to be aligned with NYDOH's criteria. 

GRAIL and Premiers PINC AI Partner to Support Patient Access to Galleri Multi-Cancer Early Detection Blood Test - Vimarsana News

GRAIL and Premiers PINC AI Partner to Support Patient Access to Galleri Multi-Cancer Early Detection Blood Test

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced a collaboration with Premier, Inc.’s PINC AI™, an advanced technology and services platform that provides artificial intelligence-enabled clinical performance improvement technologies, to support patient access to Galleri ®

GRAIL and Premier's PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test - Vimarsana News

GRAIL and Premier's PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
OmniSeq Receives New York State Approval for OmniSeq INSIGHT Genomic and Immune Profiling Test - Vimarsana News

OmniSeq Receives New York State Approval for OmniSeq INSIGHT Genomic and Immune Profiling Test

/PRNewswire/ -- OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory...